Clinical decision support

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.

According to Kevin Ritter of Altera Digital Health, health systems must go beyond simple information exchange to ensure their data is discrete, normalized and able to flow between multiple applications across the enterprise.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.

It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.

The Korean AI company also plans expansion into Vietnam and Hong Kong.

Trained on local medical laws and treatment guidelines, the model scored 96.4 on the 2025 Korean Medical Licensing Examination.

The model can also make zero-shot predictions.

Also, South Korea's Ministry of Health and Welfare has made more patient data available on the My Health Record app.

It demonstrated over 90% accuracy in detecting binary foetal movements in a hospital trial.